Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Unity Hospital
mi
from
Fridley, MN
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Unity Hospital
mi
from
Fridley, MN
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Hutchinson Area Health Care
mi
from
Hutchinson, MN
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Hutchinson Area Health Care
mi
from
Hutchinson, MN
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Saint John's Hospital - Healtheast
mi
from
Maplewood, MN
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Saint John's Hospital - Healtheast
mi
from
Maplewood, MN
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Abbott Northwestern Hospital
mi
from
Minneapolis, MN
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Abbott Northwestern Hospital
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
New Ulm Medical Center
mi
from
New Ulm, MN
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
New Ulm Medical Center
mi
from
New Ulm, MN
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
North Memorial Medical Health Center
mi
from
Robbinsdale, MN
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
North Memorial Medical Health Center
mi
from
Robbinsdale, MN
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Park Nicollet Clinic - Saint Louis Park
mi
from
Saint Louis Park, MN
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Park Nicollet Clinic - Saint Louis Park
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Regions Hospital
mi
from
Saint Paul, MN
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Regions Hospital
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
United Hospital
mi
from
Saint Paul, MN
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
United Hospital
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Saint Francis Regional Medical Center
mi
from
Shakopee, MN
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Saint Francis Regional Medical Center
mi
from
Shakopee, MN
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Lakeview Hospital
mi
from
Stillwater, MN
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Lakeview Hospital
mi
from
Stillwater, MN
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Ridgeview Medical Center
mi
from
Waconia, MN
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Ridgeview Medical Center
mi
from
Waconia, MN
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Rice Memorial Hospital
mi
from
Willmar, MN
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Rice Memorial Hospital
mi
from
Willmar, MN
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Alegent Health Lakeside Hospital
mi
from
Omaha, NE
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Alegent Health Lakeside Hospital
mi
from
Omaha, NE
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Alegent Health Bergan Mercy Medical Center
mi
from
Omaha, NE
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Alegent Health Bergan Mercy Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Creighton University Medical Center
mi
from
Omaha, NE
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Creighton University Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Nevada Cancer Institute-Summerlin Campus
mi
from
Las Vegas, NV
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Nevada Cancer Institute-Summerlin Campus
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Nevada Cancer Research Foundation CCOP
mi
from
Las Vegas, NV
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Nevada Cancer Research Foundation CCOP
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Veterans Adminstration New Jersey Health Care System
mi
from
East Orange, NJ
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Veterans Adminstration New Jersey Health Care System
mi
from
East Orange, NJ
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
New York Oncology Hematology, PC at Albany Medical Center
mi
from
Albany, NY
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
New York Oncology Hematology, PC at Albany Medical Center
mi
from
Albany, NY
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Mary Imogene Bassett Hospital
mi
from
Cooperstown, NY
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Mary Imogene Bassett Hospital
mi
from
Cooperstown, NY
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Beth Israel Med Ctr
mi
from
New York, NY
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Beth Israel Med Ctr
mi
from
New York, NY
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Sanford Roger Maris Cancer Center
mi
from
Fargo, ND
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Sanford Roger Maris Cancer Center
mi
from
Fargo, ND
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Sanford Clinic North-Fargo
mi
from
Fargo, ND
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Sanford Clinic North-Fargo
mi
from
Fargo, ND
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Sanford Medical Center-Fargo
mi
from
Fargo, ND
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Sanford Medical Center-Fargo
mi
from
Fargo, ND
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Mary Rutan Hospital
mi
from
Bellefontaine, OH
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Mary Rutan Hospital
mi
from
Bellefontaine, OH
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Strecker Cancer Center-Belpre
mi
from
Belpre, OH
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Strecker Cancer Center-Belpre
mi
from
Belpre, OH
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Aultman Health Foundation
mi
from
Canton, OH
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Aultman Health Foundation
mi
from
Canton, OH
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Adena Regional Medical Center
mi
from
Chillicothe, OH
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Adena Regional Medical Center
mi
from
Chillicothe, OH
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
MetroHealth Med Ctr
mi
from
Cleveland, OH
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
MetroHealth Med Ctr
mi
from
Cleveland, OH
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Riverside Methodist Hospital
mi
from
Columbus, OH
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Riverside Methodist Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Grant Medical Center
mi
from
Columbus, OH
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Grant Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Doctors Hospital
mi
from
Columbus, OH
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Doctors Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Columbus Oncology and Hematology Associates Inc
mi
from
Columbus, OH
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Columbus Oncology and Hematology Associates Inc
mi
from
Columbus, OH
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Delaware Health Center-Grady Cancer Center
mi
from
Delaware, OH
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Delaware Health Center-Grady Cancer Center
mi
from
Delaware, OH
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Grady Memorial Hospital
mi
from
Delaware, OH
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Grady Memorial Hospital
mi
from
Delaware, OH
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Fairfield Medical Center
mi
from
Lancaster, OH
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Fairfield Medical Center
mi
from
Lancaster, OH
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Saint Rita's Medical Center
mi
from
Lima, OH
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Saint Rita's Medical Center
mi
from
Lima, OH
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Marietta Memorial Hospital
mi
from
Marietta, OH
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Marietta Memorial Hospital
mi
from
Marietta, OH
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Knox Community Hospital
mi
from
Mount Vernon, OH
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Knox Community Hospital
mi
from
Mount Vernon, OH
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Licking Memorial Hospital
mi
from
Newark, OH
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Licking Memorial Hospital
mi
from
Newark, OH
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Southern Ohio Medical Center
mi
from
Portsmouth, OH
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Southern Ohio Medical Center
mi
from
Portsmouth, OH
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Springfield Regional Medical Center
mi
from
Springfield, OH
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Springfield Regional Medical Center
mi
from
Springfield, OH
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Trinity's Tony Teramana Cancer Center
mi
from
Steubenville, OH
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Trinity's Tony Teramana Cancer Center
mi
from
Steubenville, OH
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Bryn Mawr Hospital
mi
from
Bryn Mawr, PA
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Bryn Mawr Hospital
mi
from
Bryn Mawr, PA
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Geisinger Medical Center
mi
from
Danville, PA
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Geisinger Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Paoli Memorial Hospital
mi
from
Paoli, PA
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Paoli Memorial Hospital
mi
from
Paoli, PA
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Geisinger Medical Group
mi
from
State College, PA
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Geisinger Medical Group
mi
from
State College, PA
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Avera Cancer Institute
mi
from
Sioux Falls, SD
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Avera Cancer Institute
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Avera McKennan Hospital and University Health Center
mi
from
Sioux Falls, SD
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Avera McKennan Hospital and University Health Center
mi
from
Sioux Falls, SD
Click here to add this to my saved trials